VPAResearch: Market Research Reports

VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.

Publications found: 61,464
Sort by:

Microscopic Polyangiitis (MPA) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Microscopic Polyangiitis (MPA) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Microsco...

February 2023 40 pages

Middle East Respiratory Syndrome (MERS) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Middle East Respiratory Syndrome (MERS) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the...

February 2023 200 pages

Mild Cognitive Impairment Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Mild Cognitive Impairment Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Mild Cognitiv...

February 2023 170 pages

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For e...

February 2023 90 pages

Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For...

February 2023 80 pages

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  202...

February 2023 90 pages

Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development...

February 2023 140 pages

Mumps Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Mumps Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Mumps pipeline candidate, details...

February 2023 40 pages

Myasthenia Gravis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Myasthenia Gravis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Myasthenia Gravis pip...

February 2023 190 pages

Myocardial Fibrosis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Myocardial Fibrosis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Myocardial Fibrosis...

February 2023 60 pages

Myocardial Ischemia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Myocardial Ischemia Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Myocardial Ischemia...

February 2023 80 pages

Myocarditis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Myocarditis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Myocarditis pipeline candid...

February 2023 40 pages

Narcolepsy Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Narcolepsy Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Narcolepsy pipeline candidat...

February 2023 110 pages

Nasal Polyps (Nasal Polyposis) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Nasal Polyps (Nasal Polyposis) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Nasal Po...

February 2023 50 pages

Nasopharyngitis (Common Cold) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Nasopharyngitis (Common Cold) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Nasophary...

February 2023 40 pages

Neisseria Meningitidis Infections Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Neisseria Meningitidis Infections Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Neiss...

February 2023 110 pages

Nephrotic Syndrome Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Nephrotic Syndrome Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Nephrotic Syndrome p...

February 2023 40 pages

Neurofibromatoses Type I (Von Recklinghausen’s Disease) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Neurofibromatoses Type I (Von Recklinghausen’s Disease) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023....

February 2023 80 pages

Neurofibromatoses Type II Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Neurofibromatoses Type II Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Neurofibromat...

February 2023 50 pages

Neuromyelitis Optica (Devic’s Syndrome) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Neuromyelitis Optica (Devic’s Syndrome) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the...

February 2023 170 pages

Neutropenia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Neutropenia Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Neutropenia pipeline candid...

February 2023 130 pages

Nocturia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Nocturia Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Nocturia pipeline candidate, d...

February 2023 40 pages

Obsessive-Compulsive Disorder Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Obsessive-Compulsive Disorder Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Obsessive...

February 2023 50 pages

Ocular Hypertension Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Ocular Hypertension Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Ocular Hypertension...

February 2023 160 pages

Oligodendroglioma Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Oligodendroglioma Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Oligodendroglioma pip...

February 2023 100 pages

Onychomycosis (Tinea Unguium) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Onychomycosis (Tinea Unguium) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Onychomyc...

February 2023 100 pages

Opioid-Induced Constipation (OIC) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Opioid-Induced Constipation (OIC) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Opioi...

February 2023 40 pages

Optic Neuritis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Optic Neuritis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Optic Neuritis pipeline...

February 2023 60 pages

Optic Neuropathy Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Optic Neuropathy Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Optic Neuropathy pipel...

February 2023 40 pages

Oral Mucositis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Oral Mucositis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Oral Mucositis pipeline...

February 2023 50 pages

Organophosphate and Carbamate Poisoning Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Organophosphate and Carbamate Poisoning Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the...

February 2023 40 pages

Ornithine-Transcarbamylase Deficiency Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Ornithine-Transcarbamylase Deficiency Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the O...

February 2023 60 pages

Osteogenesis Imperfecta Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Osteogenesis Imperfecta Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Osteogenesis Im...

February 2023 60 pages

Osteomyelitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Osteomyelitis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Osteomyelitis pipeline ca...

February 2023 40 pages

Osteonecrosis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Osteonecrosis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Osteonecrosis pipeline ca...

February 2023 40 pages

Otitis Media Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Otitis Media Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Otitis Media pipeline cand...

February 2023 90 pages

Overactive Bladder Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Overactive Bladder Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Overactive Bladder p...

February 2023 120 pages

Pancreatitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Pancreatitis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Pancreatitis pipeline cand...

February 2023 130 pages

Paroxysmal Nocturnal Hemoglobinuria Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Paroxysmal Nocturnal Hemoglobinuria Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Par...

February 2023 140 pages

Peanut Allergy Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Peanut Allergy Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Peanut Allergy pipeline...

February 2023 130 pages

Pemphigus Vulgaris Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Pemphigus Vulgaris Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Pemphigus Vulgaris p...

February 2023 60 pages

Peptic Ulcers Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Peptic Ulcers Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Peptic Ulcers pipeline ca...

February 2023 110 pages

Periodontitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Periodontitis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Periodontitis pipeline ca...

February 2023 60 pages

Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1&nbs...

February 2023 190 pages

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For e...

February 2023 140 pages

Peritonitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Peritonitis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Peritonitis pipeline candid...

February 2023 50 pages

Pertussis (Whooping Cough) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Pertussis (Whooping Cough) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Pertussis (W...

February 2023 130 pages

Phenylketonuria (PKU) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Phenylketonuria (PKU) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Phenylketonuria (...

February 2023 110 pages

Pheochromocytoma Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Pheochromocytoma Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Pheochromocytoma pipel...

February 2023 60 pages

Pigmented Villonodular Synovitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Pigmented Villonodular Synovitis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Pigmen...

February 2023 40 pages

Filters

Search

Categories

1,428
60
12,968
1,223
4,429
2
1
12,593
2,818
15,138
67
8,921
1
1,229
586

Publishers

61,464

Regions

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
61,427

Price

Date

Pages

Offers